References
Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T (2018) Current perspectives on Stevens–Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol 54(1):147–176
Schneider JA, Cohen PR (2017) Stevens–Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther 34(6):1235–1244
Chen CB, Abe R, Pan RY, Wang CW, Hung SI, Tsai YG, Chung WH (2018) An updated reviewof the molecular mechanisms in drug hypersensitivity. J Immunol Res 13(2018):6431694
Mustafa SS, Ostrov D, Yerly D (2018) Severe cutaneous adverse drug reactions: presentation, risk factors, and management. Curr Allergy Asthma Rep 18(4):26
Roujeau JC, Bastuji-Garin S (2011) Systematic review of treatments for Stevens–Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf 2(3):87
Funding
No funding was obtained and there are no financial disclosures.
Author information
Authors and Affiliations
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Statement of human and animal rights
This case image complies with the ethical standards outlined in the journal. It involved the medical management of a patient as per society guidelines and was in accordance with the ethical standards of the institution.This case was not formal research involving Human participants and/or Animals.
Informed consent
Informed consent was obtained from the patient.
Rights and permissions
About this article
Cite this article
Bakshi, S.S. Stevens–Johnson syndrome. Intern Emerg Med 14, 323–324 (2019). https://doi.org/10.1007/s11739-018-1981-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-018-1981-0